WASHINGTON, Feb. 9 /PRNewswire/ -- Hunton & Williams LLP and DiNovo Price
Ellwanger & Hardy LLP filed a patent infringement suit on behalf of client
TecSec, Incorporated against several of the world's leading technology
companies. The defendants include IBM, SAS Institute, SAP, Cisco, SUN
Microsystems, Sybase, Software AG, Adobe, eBay, PayPal, and Oracle. The suit
was filed on Friday, February 5, 2010, in the U.S. District Court for the
Eastern District of Virginia.
The complaint includes allegations of infringement of 11 U.S. patents issued
to TecSec covering core encryption technology used by the defendants'
customers to protect valuable commercial data, such as credit card
information, health care information, and other information companies are
required by law ... (more)
TAMPA, FL -- (Marketwire) -- 02/09/10 -- Stem Cell Therapy International,
Inc. (OTCBB: SCII) announced that Dr. Hoon Han has been elected Chairman of
the Company's Board of Directors effective immediately.
The Company also announced the resignation of Lixian (John) Jiang from all
positions with the Company. Lixian (John) Jiang continues to be interested in
assisting the Company in an advi... (more)
HONG KONG, Feb. 9 /PRNewswire-Asia/ -- Highlights: For the nine months ended
31 December 2009: -- Turnover was HK$37,826 million, an increase of 17.30%
year-on-year, far higher than the growth rate of China's IT market. Turnover
in December hit a monthly high of HK$5,000 million -- Gross profit margin was
6.44% -- Profit attributable to the equity holders of the parent was HK$677
million... (more)
LONDON -- (Marketwire) -- 02/09/10 -- DataCert, Inc., the leading global
provider of legal operations management solutions, today announced that its
EMEA (Europe, Middle East and Africa) business achieved 60% revenue growth in
2009. Since entering the European market in 2005 and winning its first client
there, DataCert has seen its EMEA revenue grow almost 900% and has expanded
its opera... (more)
NEW YORK, Feb. 9 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq:
DCTH), a medical technology company testing its proprietary treatment system
for primary and metastatic cancers to the liver, announced today the signing
of its first research, distribution, sales and marketing agreement for its
Percutaneous Hepatic Perfusion (PHP) System (the Delcath PHP System(TM)). The
agre... (more)
Subscribe to Intellectual Property in Silicon Valley Email News Alerts
Subscribe via RSS
Ulitzer content is offered under Creative Commons "Attribution Non-Commercial No Derivatives" License.
For any reuse or distribution, you must make clear to others the license terms of this work.
The best way to do this is with a link to this web page.
Any of the above conditions can be waived if you get written permission from Ulitzer, Inc., the copyright holder.
Nothing in this license impairs or restricts the author's moral rights.